ARCHIVES

New FDA Commisioner’s Top Priorities: FDAMA Implimitation, Agency’s Science

This article is from The Cancer Letter archive.

Vol. 25 No. 01 | January 8, 1999

Download PDF Visit The Full Archive

Related Articles

NCI Plans Brain Tumor Study To Determine Risk Factors, Exposures

April 16, 1993

Centers See Trend To Integrate Control Service With Science

February 18, 1983

ACS Research Grants Hit $78.2 Million

July 18, 1986

BioMedicines Begins Kidney Cancer Study; EntreMed Moves Forward.

February 25, 2000

Researchers Identify Nine Cancer Genes-Five Linked to CLL For The First Time

December 30, 2011

In Brief: Stoval to Receive ACCC Award; Groopman, Sigal, Named to Board of Scientific Advisors

March 12, 1999